Menu
Recent updates as of 10/18/2021

Continuing Education (CE)

Funding for this conference was made possible in part by grant # 1R13AA028424-01 from National Institute on Alcohol Abuse and Alcoholism. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the NIH; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government

All speakers and planners associated with this conference submitted conflict of interest attestations. All potential conflicts were addressed so that no commercial entity influenced any content presented.


Conference Learning Objectives

Participants taking part in this conference will be able to:

  • Discuss roles of other disciplines in an interprofessional approach to research and treatment of pain, alcohol and substance use disorders.

  • Discuss the neurobiology common to pain and alcohol and substance use disorders

  • Discuss indications of clinical/translation research on placebo and mind-body intervention mechanisms in pain, alcohol and substance use disorders treatment.

  • Discuss the ethical facets of the placebo effect

  • Apply the empirical, conceptual and ethical facets of the placebo effect to research design.

  • Apply the empirical, conceptual and ethical facets of the placebo effect to treatment design for pain, alcohol and substance use disorders.


Continuing Professional Development for Nurses

Nurses may receive up to 17.5 contact hours upon successful completion of this educational activity. Successful completion of this activity for nursing continuing professional development requires viewing the entire selected session(s), completion of the online program evaluation, and submitting request and payment. Participants receive a certificate of continuing professional development contact hours via email from the University of Maryland School of Nursing approximately two to four weeks after submitting their request and required documentation. All requests for CE must be received within 30 days of registering for this activity.

To request CE please contact

sips2021@lists.umaryland.edu

The University of Maryland School of Nursing is accredited with distinction as a provider of Nursing Continuing Professional Development by the American Nurses Credentialing Center’s Commission on Accreditation.

The Office of Professional Education administers this accreditation program and works with faculty and stakeholders to provide learning activities that meet ANCC standards and provide relevant, effective, and engaging learning activities.

The University of Maryland School of Pharmacy is accredited by the Accreditation Council of Pharmacy Education as a provider of continuing pharmacy education. These activities are targeted to pharmacists. The 3rd International Conference of the Society for Interdisciplinary Placebo Studies Pharmacists is approved for a total of 43 hours of continuing pharmacy education credit. Pharmacists may earn up to 17.5 hours of continuing education credit for successful completion of approved activities. Successful completion requires participation in the entire session(s) and completion of the online CE evaluation.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society and the University of Maryland Baltimore, Society for Interdisciplinary Placebo Studies Local Planning Committee. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

MedChi designates this online enduring educational activity for a maximum of 17 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.